Research Topics
Genomes and Genes | tacrineSummarySummary: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's diseaseDong Shao
Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Graduate School of the Chinese Academy of Sciences, 555 Zhu Chong Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China
Bioorg Med Chem Lett 14:4639-42. 2004b>Tacrine-E2020 hybrids and some related compounds were prepared and their bioactivities on the Alzheimer's disease were assayed. The optimum hybrid inhibitor 3 is 37-fold more potent and 31-fold more selective than tacrine in vitro.
The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrineHua Yu
Institute of Chinese Medical Sciences, University of Macau, Macau SAR, PR China
J Pharm Biomed Anal 46:75-81. 2008The lipophilicity and solubility profiles of bis(12)-hupyridone (B12H) and bis(7)-tacrine (B7T), two novel acetylcholinesterase inhibitors dimerized from huperzine A fragments and tacrine, respectively, were investigated over a broad pH ..
Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in ratsP Chopin
Centre de Recherche Pierre Fabre, Castres, France
Psychopharmacology (Berl) 106:26-30. 1992..b>Tacrine or galanthamine, inhibitors of acetylcholinesterase, given in conjunction with scopolamine partially reversed the ..
Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channelsN N Lermontova
Department of Biological Research, Institute of Physiologically Active Substances, Russian Academy of Sciences, Chernogolovka, Moscow Region
Bull Exp Biol Med 132:1079-83. 2001..Antialzheimer preparations tacrine and dimebon improve survival of cerebellar granule cells during long-term incubation with Abeta25-35, the ..
Investigation into the in vivo effects of five novel tacrine/ferulic acid and beta-carboline derivatives on scopolamine-induced cognitive impairment in rats using radial maze paradigmChristian Fleck
Institute of Pharmacology and Toxicology, Friedrich Schiller University, Jena, Germany
Arzneimittelforschung 60:299-306. 2010Two tacrine-ferulic acid hybrids (1 A, 1 B) and three beta-carboline derivatives (BCs; 2A, 2B, 2C) were tested in vivo on 3-month-old female rats as multi-potent anti-Alzheimer drug candidates...
Tacrine derivatives and Alzheimer's diseaseV Tumiatti
Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
Curr Med Chem 17:1825-38. 2010..b>Tacrine was the first AChEI introduced in therapy...
Production and on-line acetylcholinesterase bioactivity profiling of chemical and biological degradation products of tacrineLygia Azevedo Marques
VU University Amsterdam, Faculty of Sciences, Section of Biomolecular Analysis, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
J Pharm Biomed Anal 53:609-16. 2010The present paper describes a methodology for rapid assessment of chemical and biological degradation products of tacrine and their bioactivity for acetylcholinesterase (AChE)...
Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in miceGunjan Saxena
Division of Pharmacology, Central Drug Research Institute, PO Box 173, Lucknow UP 226001, India
Eur J Pharmacol 581:283-9. 2008..Therefore, the present study was designed to investigate the influence of antidementia drugs, tacrine and donepezil, on biochemical markers of oxidative stress, glutathione (GSH) and malondialdehyde (MDA), and ..
Tacrine-NO donor and tacrine-ferulic acid hybrid molecules as new anti-Alzheimer agents: hepatotoxicity and influence on the cytochrome P450 system in comparison to tacrineAmelie Lupp
Institute of Pharmacology and Toxicology, Friedrich Schiller University, Jena, Germany
Arzneimittelforschung 60:229-37. 2010b>Tacrine (CAS 321-64-2) is a reversible acetylcholine esterase inhibitor that, despite exerting beneficial effects on Alzheimer's disease (AD), displays marked hepatotoxicity...
Furocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cellsHyuncheol Oh
Planta Med 68:463-4. 2002..0 +/- 3.4 microM. Comparison of hepatoprotective activities for six furocoumarins 1 - 6 suggested that oxy-substitution at the C-9 position increased the hepatoprotective activity...
Delayed evacuatory function due to specific smooth muscle reactivity in the gastrointestinal tracts of tacrine-treated ratsA Krustev
Department of Biophysics, Medical University, Plovdiv, Bulgaria
Pharmacology 81:50-6. 2008Most of the side effects induced by tacrine are associated with the gastrointestinal (GI) tract...
The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cellsD K Lahiri
Institute of Psychiatric Research, Departments of Psychiatry and Neurology, 791 Union Drive, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Brain Res Mol Brain Res 62:131-40. 1998..b>Tacrine, a cholinesterase inhibitor, has been shown to improve memory and cognitive functions in some patients with AD, ..
Mitochondrial proteomic analysis and characterization of the intracellular mechanisms of bis(7)-tacrine in protecting against glutamate-induced excitotoxicity in primary cultured neuronsHongjun Fu
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong, China
J Proteome Res 6:2435-46. 2007..In this study, post-treatment of cerebellar granule neurons with bis(7)-tacrine significantly reversed declines in mitochondrial membrane potential, ATP production, and neuronal cell death ..
Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidatesLei Fang
Lehrstuhl fur Pharmazeutische Medizinische Chemie, Institut fur Pharmazie, Friedrich Schiller Universitat Jena, Philosophenweg 14, D 07743 Jena, Germany
Bioorg Med Chem Lett 18:2905-9. 2008Five tacrine-ferulic acid hybrids (6a-e) were designed and synthesized as multi-potent anti-Alzheimer drug candidates...
The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's diseaseA S Rigaud
Hopital Broca, 54 56 Rue Pascal, 75013, Paris, France
Eur J Neurol 7:255-8. 2000..of our study was to evaluate the effects of the apolipoprotein E (ApoE) phenotype and gender on the response to tacrine treatment in Alzheimer's disease (AD). ApoE phenotyping was performed on 76 patients treated with tacrine for AD...
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing propertiesMaría Isabel Fernández-Bachiller
Instituto de Química Médica, Consejo Superior de Investigaciones Cientificas CSIC, Juan de la Cierva 3, 28006 Madrid, Spain
J Med Chem 53:4927-37. 2010b>Tacrine and PBT2 (an 8-hydroxyquinoline derivative) are well-known drugs that inhibit cholinesterases and decrease beta-amyloid (Abeta) levels by complexation of redox-active metals, respectively...
Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged ratsV Rispoli
Department of Pharmacobiological Sciences, University Magna Graecia of Catanzaro, Complesso Nini Barbieri, I 88021 Roccelletta di Borgia CZ, Italy
Pharmacol Biochem Behav 84:453-67. 2006..2,2-dimethylpropionate (choline pivaloyl ester) (CPE) and the Cholinesterase inhibitors (ChEIs) Tacrine (THA) and Galantamine (GAL)...
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibitionSompop Bencharit
Department of Chemistry, School of Dentistry, University of North Carolina, Chapel Hill, 27599, USA
Chem Biol 10:341-9. 2003..We determined the 2.4 A crystal structure of hCE1 in complex with tacrine, the first drug approved for treating Alzheimer's disease, and compare this structure to the Torpedo californica ..
East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine AW M Li
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China
Curr Alzheimer Res 4:386-96. 2007..The novel dimers, derived from tacrine and the fragment of huperzine A (HA'), have been demonstrated to be potent and selective reversible inhibitors of ..
Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's diseaseP Camps
Laboratori de Química Farmacèutica, Facultat de Farmacia, Universitat de Barcelona, Av Diagonal 643, E 08028, Barcelona, Spain
Mini Rev Med Chem 1:163-74. 2001b>Tacrine-huperzine A hybrids (huprines) are a new class of very potent and selective acetylcholinesterase (AChE) inhibitors. Huprines were designed from tacrine and (-)-huperzine A through a conjunctive approach...
Evidence for the involvement of central serotonergic mechanisms in cholinergic tremor induced by tacrine in Balb/c miceHina Mehta
Division of Clinical and Experimental Neurosciences, Indian Institute of Chemical Biology, Jadavpur, Calcutta
Behav Brain Res 163:227-36. 2005b>Tacrine is a potent and reversible inhibitor of acetylcholinesterase (AChE) in the brain. It produces tremor in animals, which is believed to be due to an increase in the brain acetylcholine level following AChE inhibition...
Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effectHideto Miwa
Department of Neurology, Wakayama Medical University, 811 1 Kimiidera, Wakayama City, Wakayama 641 8510, Japan
Parkinsonism Relat Disord 15:30-5. 2009To examine the mechanisms underlying the anti-tremor effect of zonisamide in rats under conditions of tacrine-induced tremulous jaw movements (TJMs).
Tacrine-induced liver damage: an analysis of 19 candidate genesAna Alfirevic
Department of Pharmacology and Therapeutics, The University of Liverpool, Sherrington Building, Ashton Street, Liverpool, UK
Pharmacogenet Genomics 17:1091-100. 2007b>Tacrine, the first acetylcholinesterase inhibitor used in the treatment of Alzheimer's disease, is associated with transaminase elevation in up to 50% of patients...
(+/-)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alterationE G Jordà
Unitat de Farmacologia i Farmacognosia, Barcelona, Spain
J Alzheimers Dis 6:577-83; discussion 673-81. 2004..b>Tacrine, (-)-huperzine A and (+/-)-huprine Y, the AChEI tested in the study, did not reverse the loss of neuronal ..
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticlesBarnabas Wilson
Department of Pharmaceutics, J S S College of Pharmacy, Ootacamund, Tamil Nadu, India
Eur J Pharm Biopharm 70:75-84. 2008The purpose of the present study was to investigate the possibility of targeting an anti-Alzheimer's drug tacrine in the brain using polymeric nanoparticles...
Action of tacrine on muscarinic receptors in rat intestinal smooth muscleM A Becerra
, Facultad de Farmacia, Universidad de Sevilla, , 41012 Sevilla, Spain
J Auton Pharmacol 21:113-9. 20011. The reversible cholinesterase inhibitor, tacrine (THA) was examined against the contractions of rat duodenum to acetylcholine and carbachol (cholinesterase resistant). 2...
Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selectionsMankil Jung
Department of Chemistry, Yonsei University, Seoul 120 749, Republic of Korea
Bioorg Med Chem Lett 17:1082-90. 2007A diverse approach to the quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity was studied using variable selections of stepwise multiple linear regression (MLR), genetic ..
Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmineQin Zhao
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People's Republic of China
Eur J Pharmacol 455:101-7. 2002Five inhibitors of acetylcholinesterase, huperzine A, donepezil, tacrine, rivastigmine and physostigmine, were compared with regard to their effects on different molecular forms of acetylcholinesterase in cerebral cortex, hippocampus, ..
Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's diseaseJiri Patocka
Center of Advanced Studies, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic
Curr Drug Metab 9:332-5. 2008b>Tacrine belongs to the group of acetylcholinesterse (AChE) inhibitors used as drugs for treatment of Alzheimer's disease (AD)...
Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthaseWenming Li
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong, China
Mol Pharmacol 71:1258-67. 2007..the NO synthase (NOS) inhibitor, N(G)-monomethyl-L-arginine (L-NMMA), and the NMDAR antagonist memantine, bis(7)-tacrine was found to be more potent in reducing NO-mediated excitotoxicity and the release of NO caused by glutamate...
Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential studyC Engeland
Department of Psychiatry and Psychology, University of Western Ontario, London, ON, Canada
Pharmacol Biochem Behav 72:457-64. 2002..Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 receiving no treatment, were administered 2 mg of nicotine polacrilex and ..
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicityT Simon
Pharmacology Department, INSERM SC4, Saint Antoine University, Paris, France
Clin Pharmacol Ther 67:432-7. 2000Glutathione conjugation of tacrine reactive metabolites depends in part on the activity of glutathione-S-transferases (GST), of which two isozymes (GST M1 and GST T1) are polymorphically expressed.
Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat bloodHua Yu
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, SAR, PR China
J Pharm Biomed Anal 44:1133-8. 2007..mass spectrometry with electrospray ionization was developed and applied for the quantification of bis(7)-tacrine (B7T) in rat blood...
Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currentsJialie Luo
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, PR China
Biochem Biophys Res Commun 361:505-9. 2007Bis(7)-tacrine has been shown to prevent glutamate-induced neuronal apoptosis by blocking NMDA receptors. However, the characteristics of the inhibition have not been fully elucidated...
Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptorsYu Wei Liu
Wuhan Institute of Neuroscience and Drug Research, Jianghan University, Wuhan 430056, PR China
Biochem Biophys Res Commun 369:1007-11. 2008We have recently reported that bis(7)-tacrine could prevent glutamate-induced neuronal apoptosis through NMDA receptors. In this study, we demonstrated that in cultured rat cortical neurons, bis(7)-tacrine (IC(50), 0...
Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptorsWenming Li
Department of Biochemistry and Biology, Hong Kong University of Science and Technology, Kowloon, Hong Kong
J Biol Chem 280:18179-88. 2005The neuroprotective properties of bis(7)-tacrine, a novel dimeric acetylcholinesterase (AChE) inhibitor, on glutamate-induced excitotoxicity were investigated in primary cultured cerebellar granule neurons (CGNs)...
Actions of tacrine and galanthamine on histamine-N-methyltransferaseO D Taraschenko
Center for Neuropharmacology and Neuroscience, Albany Medical College, New York 12208, USA
Methods Find Exp Clin Pharmacol 27:161-5. 2005..The AD medication tacrine was previously shown to inhibit some forms of rodent histamine-N-methyltransferase (HNMT), but the effects of AD ..
Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemiaYuming Zhao
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong SAR, China
Neurosci Lett 439:160-4. 2008Bis(7)-tacrine, a promising anti-Alzheimer's dimer, has been shown to have multiple neuroprotective activities in vitro. Here, we investigate whether bis(7)-tacrine attenuates focal cerebral ischemic impairment in vivo...
Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liverAbdellah Mansouri
, , Paris, France
Hepatology 38:715-25. 2003..After several weeks of treatment, levels of alanine aminotransferase (ALT) increase in 50% of patients treated with tacrine for Alzheimer's disease. We looked for progressive effects on DNA to explain delayed toxicity...
Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometryLi Zhang
Department of Biochemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, SAR, People s Republic of China
Biomed Chromatogr 22:414-20. 2008The current study aims to develop a specific and sensitive LC-MS/MS method for determination of bis(7)-tacrine (B7T) in rat plasma. A 100 microL plasma sample was extracted with ethyl acetate...
New performance of biosensor technology for Alzheimer's disease drugs: in vitro comparison of tacrine and 7-methoxytacrineMiroslav Pohanka
Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
Neuro Endocrinol Lett 29:755-8. 2008..The first was commercialized drug tacrine (known also as Cognex) used for treatment of cognitive manifestation of Alzheimer\'s disease (AD)...
Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targetsWenming Li
Department of Applied Biology and Chemical Technology, Institute of Modern Chinese Medicine, The Hong Kong Polytechnic University, Hong Kong SAR, China
Neurotherapeutics 6:187-201. 2009..decade, our group has developed several series of dimeric acetylcholinesterase (AChE) inhibitors derived from tacrine and huperzine A, a unique anti-Alzheimer's drug originally discovered from a traditional Chinese medicinal plant...
Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrineWenming Li
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong, China
Neuroreport 17:471-4. 2006Here we report that bis(7)-tacrine, a novel acetylcholinesterase inhibitor, exerts neuroprotective effects by inhibition of nitric oxide synthase...
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective propertiesMaría Isabel Fernández-Bachiller
Instituto de Química Médica, Consejo Superior de Investigaciones Cientificas CSIC, C Juan de la Cierva 3, 28006 Madrid, Spain
ChemMedChem 4:828-41. 2009b>Tacrine-melatonin hybrids were designed and synthesized as new multifunctional drug candidates for Alzheimer's disease...
Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studiesYu Wei Liu
Department of Neurobiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Neuropharmacology 54:1086-94. 2008Bis(7)-tacrine is a novel dimeric acetylcholinesterase inhibitor derived from tacrine, and has been proposed as a promising agent to treat Alzheimer's disease...
Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channelsHongjun Fu
Department of Biochemistry, Hong Kong University of Science and Technology, Hong Kong, P.R. China
J Neurochem 98:1400-10. 2006..In the current study, we investigated the effects of bis(7)-tacrine, a novel dimeric AChE inhibitor, on Abeta-induced neurotoxicity in primary cortical neurons...
Controlled release tacrine delivery system for the treatment of Alzheimer's diseaseQ Yang
College of Pharmacy and Pharmaceutical Sciences, Florida A and M University, Tallahassee, USA
Drug Deliv 8:93-8. 2001..b>Tacrine is one of the three drugs approved by the FDA for the treatment of Alzheimer's disease...
SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analoguesM Recanatini
Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, I 40126 Bologna, Italy
J Med Chem 43:2007-18. 2000..to derive a comprehensive SAR picture for the class of acetylcholinesterase (AChE) inhibitors related to tacrine, a drug currently in use for the treatment of the Alzheimer's disease...
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotypeM Sjogren
Institute of Clinical Neuroscience, Goteborg University, Sahlgrenska University Hospital Molndal, Sweden
J Neural Transm 108:451-8. 2001..To investigate the relation between tacrine treatment, inheritance of ApoE epsilon4 alleles, and rate of progression, the differences in MMSE and CIBIC ..
Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant propertiesMaría Isabel Rodríguez-Franco
Instituto de Quimica Medica CSIC, 28006 Madrid, Spain
J Med Chem 49:459-62. 2006b>Tacrine and melatonin are well-known drugs with activities as an acetylcholinesterase (AChE) inhibitor and free radical scavenger, respectively...
Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regionsNicola Simola
Department of Toxicology and Centre of Excellence for Neurobiology of Dependence, University of Cagliari, 09124, Cagliari, Italy
Exp Neurol 189:182-8. 2004Acute administration of the acetylcholinesterase inhibitor tacrine to rats induces tremulous jaw movements which can be used as a valuable model of parkinsonian tremor...
Alaternin and emodin with hydroxyl radical inhibitory and/or scavenging activities and hepatoprotective activity on tacrine-induced cytotoxicity in HepG2 cellsHyun Ah Jung
Research Institute of Marine Science and Technology, Korea Maritime University, Busan, 606-791, Korea
Arch Pharm Res 27:947-53. 2004..and emodin, to scavenge and/or inhibit hydroxyl radicals generated by the Fenton reaction and to protect tacrine-induced cytotoxicity in human liver derived HepG2 cells were evaluated, respectively...
The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the ratC Ibebunjo
Department of Anaesthesia, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada
Anesth Analg 85:431-6. 1997b>Tacrine (THA) is an anticholinesterase drug used to manage Alzheimer's dementia, but it is not clear how its chronic use might affect response to nondepolarizing muscle relaxants...
Effect of tacrine on intracellular calcium in cholinergic SN56 neuronal cellsV Dolezal
Institute of Physiology, Academy of Sciences of the Czech Republic, Videnska, Prague
Brain Res 769:219-24. 1997..We have found earlier that the depolarization-induced release of acetylcholine from the brain could be inhibited by tacrine (tetrahydroaminoacridine) but the mechanism of this action of tacrine was not clarified (S. Tucek, V. Dolezal, J...
Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in miceS Y Pan
Department of Biochemistry, Hong Kong University of Science and Technology, China
Planta Med 68:217-20. 2002Intragastric administration (100-200 micromol/kg) of tacrine (THA) or bis(7)-THA could cause an acute and dose-dependent increase in plasma alanine aminotransferases activity in mice at 6 h after the drug administration...
Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrineHans Basun
Department of Neurotec, Karolinska Institutet, Huddinge University Hospital, Sweden
Dement Geriatr Cogn Disord 14:156-60. 2002..could change the levels of Abeta in plasma, we measured Abeta42 and Abeta40 plasma levels in AD subjects before tacrine treatment and at weeks 2 and 6 of treatment...
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's diseaseP Camps
Laboratori de Quimica Farmaceutica and Departament de Fisico Quimica, Facultat de Farmacia, Universitat de Barcelona, Av Diagonal 643, E 08028 Barcelona, Spain
J Med Chem 43:4657-66. 2000Several new 12-amino-6,7,10,11-tetrahydro-7, 11-methanocycloocta[b]quinoline derivatives (tacrine-huperzine A hybrids, huprines) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors...
Tacrine interacts with different sites on nicotinic receptor subtypes in SH-SY5Y neuroblastoma and M10 cellsA L Svensson
Department of Clinical Neuroscience, Karolinska Institutet, Occupational Therapy and Elderly Care Research, Huddinge University Hospital, Sweden
Behav Brain Res 113:193-7. 2000The effect of chronic treatment with the cholinesterase inhibitor tacrine on nicotinic receptor subtypes was investigated in human SH-SY5Y neuroblastoma cells and in a fibroblast cell line (M10 cells) stably transfected with alpha4beta2 ..
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' CollaborationN Qizilbash
Department of Clinical Geratology, University of Oxford, Radcliffe Infirmary, England
JAMA 280:1777-82. 1998To determine the effects of cholinesterase inhibition with tacrine hydrochloride for the symptoms of Alzheimer disease in terms of cognitive performance, clinical global impression, behavior, and functional autonomy.
Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activityHongjun Fu
Department of Biochemistry, The Hong Kong University of Science and Technology, Hong Kong, China
Biochem Biophys Res Commun 366:631-6. 2008..In this study, the effect and mechanisms of bis(7)-tacrine (a promising anti-Alzheimer's dimer) on Abeta generation were investigated. Bis(7)-tacrine (0...
Combined tacrine and estrogen replacement therapy in patients with Alzheimer's diseaseL S Schneider
Department of Psychiatry, School of Medicine, Los Angeles, California, USA
Ann N Y Acad Sci 826:317-22. 1997..possible effects of estrogen replacement therapy (ERT) on clinical response to the cholinesterase inhibitor tacrine in women with Alzheimer's disease (AD)...
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family PhysiciansAmir Qaseem
American College of Physicians and University of Pennsylvania, Philadelphia, Pennsylvania 19106, USA
Ann Intern Med 148:370-8. 2008..The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia...
Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChED Alonso
NeuroPharma, S.A, Avda. de La Industria 52, 28760 Tres Cantos (Madrid, Spain
Bioorg Med Chem 13:6588-97. 2005A new series of donepezil-tacrine hybrid related derivatives have been synthesised as dual acetylcholinesterase inhibitors that could bind simultaneously to the peripheral and catalytic sites of the enzyme...
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregationPelayo Camps
Laboratori de Química Farmacèutica Unitat Associada al CSIC, Facultat de Farmacia, Barcelona, Spain
J Med Chem 51:3588-98. 2008A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, peripheral and midgorge binding sites of acetylcholinesterase (AChE) have been synthesized and tested for their ability to inhibit AChE, ..
Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for ADMaría Del Monte-Millán
NeuroPharma, S A, 28760 Tres Cantos, Madrid, Spain
J Mol Neurosci 30:85-8. 2006....
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guidelineParminder Raina
McMaster University, Hamilton, Ontario, Canada
Ann Intern Med 148:379-97. 2008..The effectiveness of the 5 U.S. Food and Drug Administration-approved pharmacologic therapies for dementias in achieving clinically relevant improvements is unclear...
Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrineLi Zhang
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, SAR, PR China
Int J Pharm 357:85-94. 2008The present study aims to investigate the preclinical intestinal absorption of bis(7)-tacrine (B7T) using different absorption models...
Rational approach to discover multipotent anti-Alzheimer drugsMichela Rosini
Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
J Med Chem 48:360-3. 2005..the hybrid compound lipocrine (7), whose biological profile was markedly improved relative to those of prototypes tacrine and lipoic acid...
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodiesMartine Simard
School of Psychology, Laval University, Quebec City, QC, Canada
J Neuropsychiatry Clin Neurosci 16:409-25. 2004..Methodological limitations of the existing data include small sample sizes, and the paucity of standardized psychometric measures...
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferensAfonso Caricati-Neto
Department of Pharmacology, , , Brazil
Eur J Pharmacol 503:191-201. 2004..inhibitors also increased the twitches, showing a hierarchy of potencies of galantamine>physostigmine>tacrine>rivastigmine=donepezil...
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer diseaseConstantine G Lyketsos
Am J Geriatr Psychiatry 14:561-72. 2006
Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidatesLei Fang
J Med Chem 51:713-6. 2008In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1- 14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects...
Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's diseaseMaria Laura Bolognesi
Department of Pharmaceutical Sciences, A Mangini, Alma Mater Studiorum, Bologna University, Italy
J Med Chem 50:6446-9. 2007..The lead compound bis(7)-tacrine (2) was properly modified to confer to the new molecules the ability of chelating metals, involved in the ..
Alzheimer disease and its management: a reviewMalay K Samanta
Department of Pharmaceutics, J S S College of Pharmacy, Rocklands, Ootacamund 643001, Tamil Nadu, India
Am J Ther 13:516-26. 2006..This article attempts to focus on some of the important recent developments in understanding and management of Alzheimer disease...
AAFP and ACP release guideline on dementia treatmentLisa Graham
Am Fam Physician 77:1173-5. 2008
Pharmacological characterization of orally active cholinesterase inhibitory activity of Prunus persica L. Batsch in ratsSeok-Jong Suh
Department of Biological Sciences, Sungkyunkwan University, Jangan-gu, Suwon City, Kyunggi-Do 440-746, Korea
J Mol Neurosci 29:101-7. 2006..of those of selective butyrylcholinesterase inhibitors of 9-amino-1,2,3,4-tetrahydroacridine hydrochloride (tacrine) and tetraidopropylpyrophosphoramide (iso-OMPA) and a selective AChE inhibitor, donepezil, on the cholinesterase ..
The application of evidence-based principles of care in older persons (issue 5): Alzheimer's diseaseBarbara J Zarowitz
Omnicare, Inc, Covington, KY 48150, USA
J Am Med Dir Assoc 8:183-93. 2007
[Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease]Yuki Takatori
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
Yakugaku Zasshi 126:607-16. 2006Donepezil, galanthamine, and tacrine are therapeutic acetylcholinesterase (AChE) inhibitors used for the treatment of Alzheimer's disease...
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodiesC G Ballard
Wolfson Centre for Age Related Diseases, Kings College London, London, UK
Neurology 68:1726-9. 2007..Treated patients with DLB had significantly less parenchymal Abeta deposition, which is relevant to disease management and treatment of dementia patients using ChEI...
Effect of histamine on muscimol-induced working memory deficits in radial maze performanceYasuko Yamamoto
Department of Medicinal Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700 8530, Japan
J Pharmacol Sci 104:252-7. 2007..On the other hand, no significant effect was observed with reference memory error. Donepezil and tacrine (cholinesterase inhibitors) antagonized the muscimol-induced spatial memory deficits. Histidine (1500 mg/kg, i.p...
Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer diseaseAgneta Nordberg
Neurotec Department, Division of Molecular Neuropharmacology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Alzheimer Dis Assoc Disord 20:S12-8. 2006..If such experimental in vitro observations can be extrapolated into clinical neuroprotective properties, AChE inhibitors could positively modulate the disease course of AD...
Alzheimer's disease: will advances made in the past turn the tide?Todd P Semla
Pharmacy Benefits Management and Strategic Health Group, Department of Veterans Affairs, Chicago, IL, USA
Ann Pharmacother 41:1494-6. 2007
Current and emerging pharmacological treatment options for dementiaJohn M Ringman
Department of Neurology, Alzheimer s Disease Research Center, University of California, Los Angeles, CA 90095 1769, USA
Behav Neurol 17:5-16. 2006..Their clinical utility is controversial. Many novel approaches that promise to provide more effective treatments are currently being pursued...
New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's diseaseP Szymanski
Department of Pharmaceutical Chemistry and Drug Analysis, Medical University, Lodz, Poland
Pharmazie 61:269-73. 2006..results of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition by an affinity series of tacrine-hydrazinonicotinamide hybrids are described...
Evaluation of centrally acting cholinesterase inhibitor exposures in adultsKeith R McCain
Arkansas Poison Control Center, Little Rock, AR 72205, USA
Ann Pharmacother 41:1632-7. 2007There are 4 centrally acting cholinesterase inhibitors (CA-ChEI) available in the US: tacrine, galantamine, rivastigmine, and donepezil. Documented clinical experience involving exposure to these agents is limited...
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatmentAnna Musiał
Department of Physicochemical Drug Analysis, Chair of Pharmaceutical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St, 30 688 Krakow, Poland
Curr Med Chem 14:2654-79. 2007..We have started with the analogues of the existing drugs: tacrine, donepezil, rivastigmine and galantamine which are still of interest for many research groups...
Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's diseaseCarlos H T P da Silva
, , , Av. do Caf, s/n, Monte Alegre, , Brazil
J Mol Graph Model 25:169-75. 2006..In this work we proposed molecular hybrids of tacrine with donepezil (fusion of these structures), in order to suggest new proposals of AChE inhibitors for future ..
Pharmacologic treatment options in Alzheimer's disease: optimizing disease managementPaul S Aisen
J Am Acad Nurse Pract . 2005..In addition, memantine and a ChEI appear to produce an additive effect resulting in a well-tolerated, effective treatment strategy...
Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patientsT Darreh-Shori
Karolinska Institute, Neurotec Department, Stockholm, Sweden
J Neurochem 88:1102-13. 2004..in the composition of CSF AChE variants were further pursued in AD patients treated with rivastigmine (n = 11) or tacrine (n = 17) in comparison to untreated AD patients (n = 5)...
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitorsMichael W Jann
Department of Clinical and Administrative Sciences, Southern School of Pharmacy, Mercer University, Atlanta, Georgia 30341, USA
Clin Pharmacokinet 41:719-39. 2002..This article presents the latest information on their pharmacokinetic properties and pharmacodynamic activity. Tacrine was the first cholinesterase inhibitor approved by regulatory agencies, followed by donepezil, rivastigmine and ..
Comparative effect of Prunus persica L. BATSCH-water extract and tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride) on concentration of extracellular acetylcholine in the rat hippocampusYeon Kye Kim
National Research Laboratory for Glycobiology NRLG, Korean Ministry of Science and Technology, Kyungju City, 780 714, Kyungbuk, South Korea
J Ethnopharmacol 87:149-54. 2003..the extracellular acetylcholine concentration in the hippocampus of rats were evaluated, and compared to that of tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride), a well-known and centrally acting acetylcholinesterase (AChE) ..
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patientsE A Werber
Department of Neurology, Assaf Harofe Medical Center, Zerifin, and Sackler School of Medicine, Tel Aviv University, Israel
J Neural Transm 110:659-69. 2003..Thirty-two patients suffering from dementia of several etiologies were treated with ChEIs (tacrine 19, donepezil 5, rivastigmine 8)...
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptorsMarek Samochocki
Laboratory of Molecular Neurobiology, Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Medical School, Duesbergweg 6, D 55099 Mainz, Germany
J Pharmacol Exp Ther 305:1024-36. 2003..Galantamine's APL action directly addresses the nicotinic deficit in AD...
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapySusanne Hartmann
Medical Affairs, Merz Pharmaceuticals GmbH, Frankfurt Main, Germany
Int Clin Psychopharmacol 18:81-5. 2003..Global clinical status of most patients was judged as improved (54%) or stable (39%) over the observation period. These findings particularly suggest that memantine in combination with AChEIs is safe and well tolerated...
[Protective effects of tacrine and donepezil against staurosporine-induced apoptotic death]Bai-Fang Zhang
Department of Biochemistry, School of Medicine, Wuhan University, Wuhan 430071, China
Yao Xue Xue Bao 37:98-102. 2002AIM: To study whether tacrine and donepezil can prevent cell apoptosis induced by staurosporine in NG108-15 and Hela cell lines. METHODS: MTT assay was used to examine if staurosporine impairs cell metabolism...
[Anti-dementia drugs for Alzheimer disease in present and future]Toshitama Nabeshima
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan
Nippon Yakurigaku Zasshi 120:24P-29P. 2002..We have tacrine, donepezil, rivastigmine and galantamine...
Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147Zhong Chen
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310006, China
Acta Pharmacol Sin 23:355-60. 2002..To evaluate effect of TAK-147 on spatial memory deficit induced by scopolamine...
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentialsA E Werber
Department of Neurology, Assaf Harofe Medical Center, Zerifin, Israel
Neurol Neurochir Pol 35:37-43. 2001..Thirty two patients were treated with ChEls for dementia (tacrine 19, donepezil 5, rivastigmine 8)...
Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in ratsA Jing Xu
Department of Pharmacology, School of Medicine, Zhejiang University, 310006, Hangzhou, People's Republic of China
Neurosci Lett 331:33-6. 2002..3 and 1.0 mg/kg significantly ameliorated ischemia-induced memory deficits dose-dependently, but tacrine had no appreciable effect...
Homodimeric tacrine congeners as acetylcholinesterase inhibitorsMing Kuan Hu
School of Pharmacy and Department of Pharmacology, National Defense Medical Center, 161 Section 6, Minchuan East Road Taipei, Taiwan 114, Republic of China
J Med Chem 45:2277-82. 2002In the search for highly selective and potent derivatives of tacrine (1a), a number of homodimeric tacrine congeners were synthesized and conducted for their effects on rat acetylcholinesterase (AChE) and human butyrylcholinesterase (..
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigminePhilippe Robert
Memory Centre UEC, Centre Hospitalier Universitaire de Nice, France
Curr Med Res Opin 18:156-71. 2002..Differences seen between the agents in terms of efficacy in BPSD, tolerability and safety profiles may be the result of differences in neuropharmacological profiles...
Research Grants
- Determining Therapeutic Efficacy of AGE in ADNeelima Chauhan; Fiscal Year: 2005..and cholinergic system regulate APP processing, current Alzheimer's therapy targets cholinergic enhancement [Tacrine, Aricept/Donezepil, Rivastigmine, Galantamine]; and regulation of inflammation by NSAIDs [Aspirin, Ibuprofen, ..
- MOTOR EFFECTS OF ATYPICAL ANTIPSYCHOTICSJohn Salamone; Fiscal Year: 2003..In addition, clozapine acts to suppress the jaw movements induce by the anticholinesterase tacrine. The suppression of tacrine-induced jaw movements by clozapine occurs at a relatively low dose; clozapine ..
- CHOLINERGIC & GABAERGIC MECHANISM SEPTOHIPPOCAMPAL PATHWAYMeenakshi Alreja; Fiscal Year: 2005..In contrast, a wide array of AChEIs, including the clinically used tacrine, produce a profound increase in the firing activity of MSDB neurons, which is blocked by Atr/Scop...
- RECEPTOR/G-PROTEIN COUPLING IN ALZHEIMER'S DISEASEJohn Lee; Fiscal Year: 2001..g. bethanechol) or enhance the synaptic availability of acetylcholine (e.g. tacrine, arecept)...
- CHRONIC CHANGES IN NEUROTRANSMISSION FOLLOWING TBIC Dixon; Fiscal Year: 1999..increases in cholinergic tone produced by administration of a cholinesterase inhibitor tetrahydrominoacridine (tacrine) will attenuate behavioral and neurochemical deficits in cholinergic neurotransmission in the hippocampus and ..
- Pharmacotherapy for Minor DepressionRobert Howland; Fiscal Year: 2004..The results of this study will have profound public health implications by improving our understanding of the efficacy of SJW and standard antidepressants for the treatment of MinorD. ..
- Cognitive-Behavioral Therapy & Glutametergic Neurometabolites in Pediatric OCDJOSEPH O NEILL; Fiscal Year: 2009..This proposal aims for a better understanding of the brain mechanisms of cognitive-behavioral therapy (CBT) in order to develop novel therapies and improve the success of existing therapies. ..
- Ion Channels and Chemicals Controlling Synapse StabilityJoseph McArdle; Fiscal Year: 2006..The knowledge gained from this research will enlighten future molecular approaches to treating pathologies which afflict children and adults. ..
- Mechanisms of Cholinesterase Inhibitors on Beta-amyloidDebomoy Lahiri; Fiscal Year: 2006..Three FDA- approved drugs (tacrine, donepezil and rivastigmine) for treating AD subjects belong to the category of cholinesterase (ChE) inhibitor (..
- Cholinesterase Inhibitors in Alzheimer's DiseaseDebomoy Lahiri; Fiscal Year: 2009..The outcome of the proposal is to identify mechanisms by which ChEIs block potentially toxic AB levels and to utilize this property in developing novel therapeutic agents. ..
- Magnetic Resonance Spectroscopic Imaging of the Brain in Methamphetamine AbuseJOSEPH O NEILL; Fiscal Year: 2007..This proposal aims for a better understanding of the state of the brain during very early abstinence from methamphetamine in order to develop novel therapies and improve the success of existing therapies. ..
- Cognitive-Behavioral Therapy & Glutametergic Neurometabolites in Pediatric OCDJohn C Piacentini; Fiscal Year: 2010..This proposal aims for a better understanding of the brain mechanisms of cognitive-behavioral therapy (CBT) in order to develop novel therapies and improve the success of existing therapies. ..
- Regulation of APP Pathway Gene Promoters in Alzheimer'sDebomoy Lahiri; Fiscal Year: 2007..Studying APP and BACE gene regulation is crucial to understand APP production leading to Aa generation. These studies should help developing suitable drug targets for the treatment of Alzheimer's disease. ..
- Cholinesterase Inhibitors in Alzheimer's DiseaseDebomoy K Lahiri; Fiscal Year: 2010..The outcome of the proposal is to identify mechanisms by which ChEIs block potentially toxic AB levels and to utilize this property in developing novel therapeutic agents. ..
- Cognitive-Behavioral Therapy & Glutametergic Neurometabolites in Pediatric OCDJohn C Piacentini; Fiscal Year: 2010..This proposal aims for a better understanding of the brain mechanisms of cognitive-behavioral therapy (CBT) in order to develop novel therapies and improve the success of existing therapies. ..
- Regulation of APP Pathway Gene Promoters in Alzheimer'sDebomoy Lahiri; Fiscal Year: 2009..Studying APP and BACE gene regulation is crucial to understand APP production leading to Aa generation. These studies should help developing suitable drug targets for the treatment of Alzheimer's disease. ..
- 1H MRSI/Response Inhibition/Methamphetamine AbusersJOSEPH O NEILL; Fiscal Year: 2005..This project will examine the chemistry of parts of the brain thought to be responsible for inhibition and/or damaged by methamphetamine in methamphetamine addicts. ..
- NEURAL CIRCUITRY MEDIATING SUCROSE INDUCED ANALGESIAMatthew Ennis; Fiscal Year: 2003..This work will lead to a better understanding of neural circuits controlling taste and pain and how these circuits regulate analgesia in newborns. ..
- APP GENE PROMOTER IN ALZHEIMER'S DISEASEDebomoy Lahiri; Fiscal Year: 2004..Understanding the complex interplay between the promoter domains and the transcription factors may suggest novel methods for therapeutic intervention. ..
- CANDIDATE GENES FOR ALZHEIMER'S DISEASE RISK IN BLACKSRebecca Evans; Fiscal Year: 2005..This career enhancement plan will enable Dr. Evans to develop expertise in patient-oriented research, and help her accomplish her goal of becoming an independent investigator. ..
- FMRI in Pre-Symptomatic PS1-related Alzheimer's DiseaseJohn Ringman; Fiscal Year: 2005..UCI, with its strong dementia research program, growing MRI capabilities and opportunity to collaborate at the nearby UCLA Brain Imaging Center, is an excellent environment for this endeavor. ..
- SOCIAL FACTORS AND EPIDEMIOLOGY OF COGNITIVE DECLINEMarie Florence Shadlen; Fiscal Year: 2005..Hence, these projects will allow Dr Shadlen to achieve her 5-year goal of synthesis of her interests in racial differences, dementia, and epidemiology into an independent, thought-provoking research program. ..
